750 Preclinical characteristics of ITMN-B, an orally active inhibitor of the HCV NS3/4A protease nominated for preclinical development

✍ Scribed by S.D. Seiwert; S.W. Andrews; H. Tan; T. Wang; B. Marafino; R. Rieger; J. Pheneger; P.A. Lee; Y. Jiang; A.L. Kennedy; J. Ballard; H. Zhang; B. Bernat; K.R. Condrosld; C. Lemieux; B. Brandhuber; J.A. Josey; L.M. Blatt

• Book ID: 117375026
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 58 KB
• Volume: 44
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(06)80751-8